Cite
Trenkwalder P, Dahl K, Lehtovirta M, et al. Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension. Blood Press. 2000;9:57doi: 10.1080/080370500439308.
Trenkwalder, P., Dahl, K., Lehtovirta, M., & Mulder, H. (2000). Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension. Blood pressure, 957. https://doi.org/10.1080/080370500439308
Trenkwalder, P, et al. "Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension." Blood pressure vol. 9 (2000): 57. doi: https://doi.org/10.1080/080370500439308
Trenkwalder P, Dahl K, Lehtovirta M, Mulder H. Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension. Blood Press. 2000;9:57. doi: 10.1080/080370500439308. PMID: 28425802.
Copy
Download .nbib